Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 21 ~ 40 of 2699, Page 2 of 136
21. Medtronic Announces Cash Tender Offers for up to $4.175 Billion of Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.
06/24/2019 Medtronic
22. Medtronic Supports CMS Ruling on TAVR National Coverage Determination
Medtronic plc (NYSE:MDT) today issued the following statement regarding the final decision memo updating the TAVR National Coverage Determination (NCD) 20.32 announced by the Centers for Medicare & Medicaid Services (CMS)
06/21/2019 Medtronic
23. Medtronic Announces 8 Percent Increase in Cash Dividend
42nd Consecutive Year of Dividend Increases
06/21/2019 Medtronic
24. Medtronic Statement Regarding FDA Circulatory System Devices Panel
Medical Devices Advisory Committee on paclitaxel-coated therapies in patients with peripheral artery disease (PAD) in the superficial femoropopliteal artery (SFA)
06/20/2019 Medtronic
25. Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation / Assay is the first and only rapid point-of-care test cleared by the U.S. Food and Drug Administration (FDA) to aid healthcare professionals in the diagnosis of diabetes
06/17/2019 Abbott
26. IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products
06/13/2019 MERCK
27. Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes
ugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
06/10/2019 Medtronic
28. Merck to Acquire Tilos Therapeutics
Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ
06/10/2019 MERCK
29. Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
Four Year Partnership Made Public Today
06/10/2019 Medtronic
30. Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases
FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons
05/16/2019 Medtronic
31. Smarter research & development to tackle global health priorities
WHO Chief Scientist invites global health R&D community to contribute to the Directory
05/15/2019 WHO
32. Medtronic Reveals Results of First-In-Human Study for Investigational Extravascular ICD System
Company to Proceed with Plans for Future Pivotal Study of New ICD System
05/11/2019 Medtronic
33. WHO is establishing technical advisory group and roster of experts on digital health
05/10/2019 WHO
34. Medtronic Enters Into Definitive Agreement to Acquire Titan Spine
(GLOBE NEWSWIRE via COMTEX) --Acquisition Further Accelerates Medtronic''s Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions
05/09/2019 Medtronic
35. Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health, on new steps to help reduce risks associated with surgical staplers for internal use and implantable staples
04/23/2019 U.S. FOOD & DRUG ADMINISTRATION
36. Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agency’s new steps to strengthen the process of initiating voluntary recalls
04/23/2019 U.S. FOOD & DRUG ADMINISTRATION
37. FDA permits marketing of first medical device for treatment of ADHD
04/19/2019 U.S. FOOD & DRUG ADMINISTRATION
38. Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease
Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London. The new data demonstrate durable and consistent long-term outcomes of the Medtronic VenaSeal(TM) Closure System in treating patients with chronic venous disease.
04/17/2019 Medtronic
39. Medtronic Data Expands on Key Aortic Solutions for Challenging Anatomies
New EndoSuture Aneurysm Repair (ESAR) and Valiant Navion(TM) Data Presented at Charing Cross Demonstrate Safety and Efficacy in Patients with Complex Anatomies
04/17/2019 Medtronic
40. FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to remove all devices from the market
04/16/2019 U.S. FOOD & DRUG ADMINISTRATION
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱